Compare CSV & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CSV | CTKB |
|---|---|---|
| Founded | 1991 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 643.0M | 541.1M |
| IPO Year | 1996 | 2021 |
| Metric | CSV | CTKB |
|---|---|---|
| Price | $37.88 | $4.62 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 4 |
| Target Price | ★ $59.00 | $5.63 |
| AVG Volume (30 Days) | 125.5K | ★ 2.2M |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.92% | N/A |
| EPS Growth | ★ 54.76 | N/A |
| EPS | ★ 0.84 | N/A |
| Revenue | ★ $417,440,000.00 | $193,015,000.00 |
| Revenue This Year | $7.35 | $5.42 |
| Revenue Next Year | $3.87 | $7.03 |
| P/E Ratio | $45.32 | ★ N/A |
| Revenue Growth | 3.28 | ★ 17.67 |
| 52 Week Low | $37.11 | $3.09 |
| 52 Week High | $52.10 | $6.18 |
| Indicator | CSV | CTKB |
|---|---|---|
| Relative Strength Index (RSI) | 41.74 | 59.89 |
| Support Level | $37.13 | $4.56 |
| Resistance Level | $44.62 | $4.80 |
| Average True Range (ATR) | 1.13 | 0.22 |
| MACD | 0.17 | 0.03 |
| Stochastic Oscillator | 28.42 | 86.53 |
Carriage Services Inc is a provider of funeral and cemetery services and merchandise in the United States. It operates in two business segments: The Funeral Home Operations segment offers burial, cremation, and consultation services; removes and prepares remains; sells caskets, urns, and related funeral merchandise. The company enables the use of funeral home facilities for visitation, remembrance, and transportation services. The Cemetery Operations segment provides services, such as mausoleum spaces and niches, private estates, lawn crypt gardens, traditional single burial gravesites, and burial vaults. The majority of revenue is derived from The Funeral Home Operations segment.
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.